Short at­tack tar­gets one of the fa­vorites now shar­ing the lead in the pop­u­lar KRAS drug de­vel­op­ment race

Sahm Ad­ran­gi’s short-at­tack team at Ker­ris­dale is out to slam one of the most pop­u­lar biotech plays in the book this morn­ing.

The tar­get is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.